TNGX Latest Headlines

Tango Therapeutics’ $600 Million Upsized Public Offering Sets Stage for Expansion

Market Chameleon (Wed, 10-Jun 8:56 AM)

Tango Therapeutics Issues Major Inducement Equity Grants at Key Inflection Point

Market Chameleon (Mon, 8-Jun 10:30 AM)

Tango Therapeutics Hits 92% Response Rate in Pancreatic Cancer Trial—Could This Chemotherapy-Free Combo Reshape the Standard of Care?

Market Chameleon (Mon, 8-Jun 7:30 AM)

Strong Cash Position and Pipeline Advances Define Tango Therapeutics’ Q1 2026 Update

Market Chameleon (Thu, 14-May 11:24 AM)